TipRanks
Advertisement
Advertisement

TEVA Stock Latest News

Teva price target raised to $47 from $42 at Barclays
The FlyTeva price target raised to $47 from $42 at Barclays
5d ago
TEVA
Salveen Richter Reiterates Buy on Teva, Sets $50 12-Month Target Backed by EV/EBITDA Valuation Ahead of Q3 Earnings
PremiumRatings
Salveen Richter Reiterates Buy on Teva, Sets $50 12-Month Target Backed by EV/EBITDA Valuation Ahead of Q3 Earnings
6d ago
TEVA
Teva price target raised to $50 from $40 at JPMorgan
PremiumThe Fly
Teva price target raised to $50 from $40 at JPMorgan
8d ago
TEVA
Midday Fly By: SpaceX buys spectrum, Delta cuts earnings guidance
PremiumThe Fly
Midday Fly By: SpaceX buys spectrum, Delta cuts earnings guidance
11d ago
T
BA
Teva announces FDA approval for Weltruza
PremiumThe Fly
Teva announces FDA approval for Weltruza
11d ago
TEVA
First Tracks Biotherapeutics price target raised to $62 from $55 at Wells Fargo
PremiumThe FlyFirst Tracks Biotherapeutics price target raised to $62 from $55 at Wells Fargo
11d ago
ARGX
TEVA
Teva call volume above normal and directionally bullish
Premium
The Fly
Teva call volume above normal and directionally bullish
13d ago
TEVA
Teva announces published review on dopamine pathways in Tourette syndrome
Premium
The Fly
Teva announces published review on dopamine pathways in Tourette syndrome
18d ago
TEVA
Teva announces new data for ecopipam
PremiumThe Fly
Teva announces new data for ecopipam
18d ago
TEVA
Exxon Mobil downgraded, BP upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Exxon Mobil downgraded, BP upgraded: Wall Street’s top analyst calls
19d ago
BP
ED
Teva, Samsung Bioepis expand strategic partnership to advance biosimilars
PremiumThe Fly
Teva, Samsung Bioepis expand strategic partnership to advance biosimilars
19d ago
TEVA
Teva initiated with a Buy at TD Cowen
PremiumThe Fly
Teva initiated with a Buy at TD Cowen
19d ago
TEVA
Teva announces FDA approval of Degevma as a biosimilar to Xgeva
PremiumThe FlyTeva announces FDA approval of Degevma as a biosimilar to Xgeva
22d ago
TEVA
Teva Rated Buy on Improving Balance Sheet, Emerging Pipeline, and Modest Upside to Current Share Price
Premium
Ratings
Teva Rated Buy on Improving Balance Sheet, Emerging Pipeline, and Modest Upside to Current Share Price
26d ago
TEVA
Microsoft upgraded, HubSpot initiated: Wall Street’s top analyst calls
Premium
The Fly
Microsoft upgraded, HubSpot initiated: Wall Street’s top analyst calls
27d ago
ALV
ARX
Teva initiated with an Outperform at Oppenheimer
PremiumThe Fly
Teva initiated with an Outperform at Oppenheimer
27d ago
TEVA
Teva presents new new real-world data on uzedy at Psych Congress
PremiumThe Fly
Teva presents new new real-world data on uzedy at Psych Congress
1M ago
TEVA
Teva announces new olanzapine post-hoc data
PremiumThe Fly
Teva announces new olanzapine post-hoc data
1M ago
TEVA
Teva Pharmaceutical Announces New Senior Notes Offering
PremiumCompany Announcements
Teva Pharmaceutical Announces New Senior Notes Offering
1M ago
8K
TEVA
Safe Pro Group (NASDAQ: SPAI) Draws WhaleWatchAlerts Attention Following Phillip Frost’s $4M Share Purchase
PremiumTipRanks NewswireSafe Pro Group (NASDAQ: SPAI) Draws WhaleWatchAlerts Attention Following Phillip Frost’s $4M Share Purchase
1M ago
OPK
SPAI
Teva Pharmaceutical Announces Major Senior Notes Financing
Premium
Company Announcements
Teva Pharmaceutical Announces Major Senior Notes Financing
1M ago
8K
TEVA
Leerink starts Teva with an Outperform with new strategy ‘clearly bearing fruit’
Premium
The Fly
Leerink starts Teva with an Outperform with new strategy ‘clearly bearing fruit’
1M ago
TEVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >